Text Size
- News Releases
- What's New
- 10 May
- Chugai Reached Agreement with Japanese Government regarding Investigational Antibody Cocktail (casirivimab and imdevimab) for COVID-19
- 10 May
- Chugai Discontinues Marketing of Photodynamic Diagnostic Agent "ALAGLIO® Divided Granules 1.5g"
- 06 May
- Research Collaboration by Chugai, the University of Tokyo and RIKEN on Functional Genome Database Published in Cell
- 26 Apr
- CHMP Recommends EU Approval of Chugai’s Enspryng (Satralizumab) for Neuromyelitis Optica Spectrum Disorder (NMOSD)
- 22 Apr
- Notice of Completion of Disposal of Treasury Shares as Restricted Stock Compensation Plan
Video Introduction of CHUGAI- Share this site
